[Clinical features and diagnosis of secondary adrenal insufficiency followed complex treatment nonpituitary brain tumors].

Autor:	Yudina AE; I.M. Sechenov First Moscow State Medical University (Sechenov University)., Pavlova MG; I.M. Sechenov First Moscow State Medical University (Sechenov University)., Sotnikov VM; Russian Scientific Center of Roentgeno-Radiology., Yudina AE; I.M. Sechenov First Moscow State Medical University (Sechenov University)., Sych YP; I.M. Sechenov First Moscow State Medical University (Sechenov University)., Mazerkina NA; N.N. Burdenko National Scientific and Practical Center for Neurosurgery., Zheludkova OG; Russian Scientific Center of Roentgenoradiology., Teryaeva NB; Russian Scientific Center of Roentgenoradiology., Gerasimov AN; I.M. Sechenov First Moscow State Medical University (Sechenov University)., Martynova E; I.M. Sechenov First Moscow State Medical University (Sechenov University)., Kim EI; I.M. Sechenov First Moscow State Medical University (Sechenov University)., Berkovskaya MA; I.M. Sechenov First Moscow State Medical University (Sechenov University).
Jazyk:	ruština
Zdroj:	Problemy endokrinologii [Probl Endokrinol (Mosk)] 2019 Nov 23; Vol. 65 (5), pp. 330-340. Date of Electronic Publication: 2019 Nov 23.
DOI:	10.14341/probl10246
Abstrakt:	Background: The most of the current studies include patients who are different by the etiology of secondary adrenal insufficiency (SAI), or investigate SAI among other late effects of the radiation therapy. Aims: To describe the features of SAI and to select the best method of screening SAI in adult patients followed complex treatment of nonpituitary brain tumors in childhood. Materials and Methods: It was the retrospective cross-sectional study. 31 patients after the complex treatment of nonpituitary brain tumors in childhood and 20 healthy volunteers were examined. Age and sex ratio were comparable between the groups. Biochemical and clinical blood tests, levels of cortisol, ACTH, DHEA-C were evaluated. The insulin tolerance test (ITT) was performed for all patients and 11 volunteers. Results: The prevalence of SAI by ITT was 45.2%. The levels of basal cortisol (BC) were significantly higher in patients without SAI in comparison with the SAI group and volunteers (505 [340; 650] vs 323 [233; 382] and 372 [263; 489] nmol / l; pSAI- without_SAI=0.001; pwihtout_SAI-healthy = 0.04). The SAI group had DHEA-C significantly lower than in other groups one (3.1 [1.8; 3.4] vs 5.1 [2.5; 6.4] and 6.8 [4.1; 8.9]; рSAI- without_SAI = 0.036; pSAI-healthy = 0.001). ROC analysis showed that BC and DHEA-S can be used as high-quality screening tests for SAI (AUC = 89.3% and 88.3%). The maximum level of cortisol (656 [608-686] vs 634 [548-677]; p = 1) and the time of its increase (45 and 60 min) did not differ during ITT in patients without SAI and volunteers. Side effects: delayed hypoglycemia occurred in 4/14 patients of the SAI group 4090 minutes late of injection 60-80 ml of 40% glucose solution for stopping hypoglycemia in the test. Conclusions: 45.2% of patients followed craniospinal irradiation had SAI that is characterized by a decrease in DHEA-C levels. A highly normal level of basal cortisol was observed in 45% of patients without SAI. DHEA-C and blood cortisol can be used for SAI screening.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu